These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27335374)

  • 1. MICS, an easily ignored contributor to arterial calcification in CKD patients.
    Zhang K; Gao J; Chen J; Liu X; Cai Q; Liu P; Huang H
    Am J Physiol Renal Physiol; 2016 Oct; 311(4):F663-F670. PubMed ID: 27335374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging cross-talks between chronic kidney disease-mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis.
    Yamada S; Tsuruya K; Kitazono T; Nakano T
    Clin Exp Nephrol; 2022 Jul; 26(7):613-629. PubMed ID: 35353283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease.
    Peev V; Nayer A; Contreras G
    Curr Opin Lipidol; 2014 Feb; 25(1):54-60. PubMed ID: 24345987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?
    Kalantar-Zadeh K
    Semin Dial; 2005; 18(5):365-9. PubMed ID: 16191172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malnutrition Inflammation Complex Syndrome in Pre-dialysis Chronic Kidney Disease Patients in a Nigerian Tertiary Hospital.
    Ucha I; Mamven M; Adejumo O; Nwankwo EA
    West Afr J Med; 2022 Dec; 39(12):1253-1259. PubMed ID: 36580888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vascular calcification in chronic kidney disease].
    Battaglia Y; Russo L; Asimakopoulos G; Storari A
    G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.
    Yamada S; Tokumoto M; Tatsumoto N; Taniguchi M; Noguchi H; Nakano T; Masutani K; Ooboshi H; Tsuruya K; Kitazono T
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1418-28. PubMed ID: 24808541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive Strategies for Vascular Calcification in Patients with Chronic Kidney Disease.
    Shigematsu T; Sonou T; Ohya M; Yokoyama K; Yoshida H; Yokoo T; Okuda K; Masumoto AR; Iwashita Y; Iseki K; Kunimoto S; Yamano Y
    Contrib Nephrol; 2017; 189():169-177. PubMed ID: 27951564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria and vascular calcification in chronic kidney disease: Lessons learned from the past to improve future therapy.
    Pongsuwan K; Kusirisin P; Narongkiattikhun P; Chattipakorn SC; Chattipakorn N
    J Cell Physiol; 2022 Dec; 237(12):4369-4396. PubMed ID: 36183389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineral metabolism and cardiovascular disease in CKD.
    Fujii H; Joki N
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):53-63. PubMed ID: 28062938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease.
    Zoccali C; London G
    Nephrol Dial Transplant; 2015 Mar; 30(3):352-7. PubMed ID: 25712936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the mechanisms in vascular calcification during chronic kidney disease.
    Voelkl J; Cejka D; Alesutan I
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):289-296. PubMed ID: 30985336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Point of note in the treatment of osteoporotic patients complicated with chronic kidney disease].
    Inaba M
    Clin Calcium; 2016 Sep; 26(9):1277-85. PubMed ID: 27561342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.
    Bansal N
    Semin Nephrol; 2017 Mar; 37(2):120-131. PubMed ID: 28410646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Updates on Lifestyle-Related Diseases and Bone Metabolism. CKD-related osteoporosis].
    Yamada S; Inaba M
    Clin Calcium; 2014 Nov; 24(11):1605-13. PubMed ID: 25355144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular diseases in CKD-MBD].
    Shioi A
    Clin Calcium; 2016 Jun; 26(6):883-8. PubMed ID: 27230844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in the Management of Vascular Calcification in Patients with End-Stage Renal Disease.
    Nitta K; Ogawa T; Hanafusa N; Tsuchiya K
    Contrib Nephrol; 2019; 198():62-72. PubMed ID: 30991406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and the bone-vascular axis in end-stage renal disease.
    Viaene L; Behets GJ; Heye S; Claes K; Monbaliu D; Pirenne J; D'Haese PC; Evenepoel P
    Osteoporos Int; 2016 Feb; 27(2):489-97. PubMed ID: 26294291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.